BAALC and acute myeloid leukemia: Yoon et al. [33] analyzed a cohort of 125 cytogenetically normal AML patients of whom approximately half were consolidated with an allogeneic HSCT and did not observe a prognostic impact of high BAALC expression levels, which might be explained by the mixed consolidation therapies.